Trimarchi Thomas
- SEC CIK
- 0002030813
In the past year, 3 open-market sale filings worth $3.03M and no purchases.
Current role at each company
- BBIO BridgeBio Pharma, Inc.President and CFOas of Aug 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.03M
- 3 filings
- Net
- −$3.03M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Trimarchi Thomas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2026 (view filing) | May 18 | 1 day | Trimarchi ThomasPresident and CFO | SSale | −13.7K | $65.08 | −$888.5K | −3.7%359.2K after | 2 lots10b5-1 |
| Feb 18, 2026 (view filing) | Feb 17 | 1 day | Trimarchi ThomasPresident and CFO | SSale | −13.6K | $74.72 | −$1.02M | −3.9%336.6K after | 2 lots10b5-1 |
| Nov 18, 2025 (view filing) | Nov 17 | 1 day | Trimarchi ThomasPresident and CFO | SSale | −16.9K | $66.46 | −$1.13M | −4.2%382.8K after | 2 lots10b5-1 |
| Aug 22, 2025 (view filing) | Aug 21 | 1 day | Trimarchi ThomasPresident and CFO | SSale | −42.2K | $49.48 | −$2.09M | −9.1%421.1K after | |
| Aug 19, 2025 (view filing) | Aug 18 | 1 day | Trimarchi ThomasPresident and CFO | SSale | −17.4K | $50.23 | −$871.7K | −3.6%463.3K after | 2 lots10b5-1 |